RX-10001

Resolvyx Pharmaceuticals, Inc · Phase 1 active Small molecule

At a glance

Generic name	RX-10001
Sponsor	Resolvyx Pharmaceuticals, Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

RX-10001 CI brief — competitive landscape report
RX-10001 updates RSS · CI watch RSS
Resolvyx Pharmaceuticals, Inc portfolio CI